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Abstract
Objective: To synthesise qualitative evidence related to barriers and facilitators of
flexible sigmoidoscopy screening (FSS) intention and uptake, particularly within low
socio-demographic uptake groups. FSS uptake is lower amongst women, lower socio-
economic status (SES), and Asian ethnic groups within the United Kingdom (UK) and
United States of America.
Methods: A total of 12 168 articles were identified from searches of four databases:
EMBASE, MEDLINE, PsycINFO and Web of Science. Eligibility criteria included: indi-
viduals eligible to attend FSS and empirical peer-reviewed studies that analysed qual-
itative data. The Critical Appraisal Skills Program tool evaluated the methodological
quality of included studies, and thematic synthesis was used to analyse the data.
Results: Ten qualitative studies met the inclusion criteria. Key barriers to FSS inten-
tion and uptake centred upon procedural anxieties. Women, including UK Asian
women, reported shame and embarrassment, anticipated pain, perforation risk, and
test preparation difficulties to elevate anxiety levels. Religious and cultural-influenced
health beliefs amongst UK Asian groups were reported to inhibit FSS intention and
uptake. Competing priorities, such as caring commitments, particularly impeded
women's ability to attend certain FSS appointments. The review identified a knowl-
edge gap concerning factors especially associated with FSS participation amongst
lower SES groups.
Conclusions: Studies mostly focussed on barriers and facilitators of intention to par-
ticipate in FSS, particularly within UK Asian groups. To determine the barriers associ-
ated with FSS uptake, and further understand how screening intention translates to
behaviour, it is important that future qualitative research is equally directed towards
factors associated with screening behaviour.
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1 | BACKGROUND
An average of 42 042 new cases of colorectal cancer were diagnosed
yearly in the United Kingdom (UK) between 2014 and 2016,1 with 1.80
million cases estimated annually worldwide (2018).2 Colorectal cancer is
the second most common cause of cancer mortality, both in the UK and
globally, with around 16 300 deaths reported every year in the UK
between 2015 and 2017,1 and 862 000 worldwide (2018).2 In 2013,
the National Health Service (NHS) England introduced the Bowel Scope
Screening Programme (BSSP), within the Bowel Cancer Screening Pro-
gramme (BCSP). A once-only flexible sigmoidoscopy screening (FSS)
procedure offered to men and women in England aged 55, available to
be taken up to the age of 60. The sigmoidoscope inspects the rectum
and sigmoid colon to identify and remove polyps which can potentially
grow and become cancerous; it can also detect whether colorectal can-
cer is present.3 The NHS BCSP England,3 Scotland4 and Wales5 also
offers men and women aged 60 to 74 (50-74 in Scotland) a home test-
ing kit, comprising of a faecal immunochemical test (FIT) issued for com-
pletion every 2 years.3-5 The FIT has replaced the faecal occult blood
test (FOBt), given FIT requires one sample rather than three to be pro-
vided and has improved sensitivity.6 The BSSP and the home testing kit
both provide a means of early detection of colorectal cancer, though the
primary purpose of FSS is to prevent cancer.3 A FSS UK trial reported
FSS to have long lasting benefits, reducing colorectal cancer incidence
by 33% at 10 years, and mortality levels by 43% at 15 years, since trial
randomisation.7 Despite such benefits, FSS uptake was reported in
England to be 43.1% during the first 14 months of the BSSP between
March 2013 and 8 May 2014 FSS has the lowest participation rate of
all organised NHS screening programs, both in comparison with stool-
based colorectal cancer testing8 and in contrast with breast and cervical
screening.9,10 In comparison to the UK, the United States Preventive
Services Task Force (USPSTF) recommends colorectal cancer screening
to start at 50 years of age, with home tests completed annually and flex-
ible sigmoidoscopy every 3 to 5 years.11 In 2015, 60.3% of adults in the
United States aged 50 and above reported to have had either a sigmoid-
oscopy in the past 5 years or a colonoscopy in the past 10 years.12
Flexible sigmoidoscopy screening uptake has been reported to be
lower amongst women,13-25 in contrast FOBt and FIT colorectal cancer
screening, have reported higher uptake among women.26,27Consistent
with other forms of cancer screening, there is a socio-economic status
(SES) gradient in FSS uptake,28 ranging from 33% to 53% in most to
least deprived quintiles in England.13 A recent review by Kerrison
et al.25 found deprivation,13,15,20,29-34 low levels of education,20,23,31,35
low income,23,36 and being unemployed30 to be significant barriers to
FSS uptake. Studies have highlighted disparities by ethnicity in colorec-
tal cancer screening uptake.16-18,25,37,38 FSS uptake has been found to
be lower among UK Asians (54%) compared to White (69%) or Black
(80%) respondents.37 Study findings did not however show screening
intention to differ by ethnicity, further understanding of the factors
which contribute to this intention-behaviour gap found within Asian
communities in England37 warrants additional review.
Research in the UK and US found people who perceived fewer
barriers14,15,29,30,39-41 and more benefits14,15,29,30,42 to the FSS test
were significantly more likely to participate in FSS. More specifically,
an unwillingness to complete test preparations, lack of provider rec-
ommendation,31,32 fear of test pain or discomfort,29,42 and lack of test
awareness43 were reported as key barriers, albeit further research is
needed to confirm the significance of these barriers on FSS uptake.44-
47 Furthermore, key health and lifestyle factors found to significantly
increase FSS uptake25 were: having a family history of colorectal can-
cer,18,24,30,36,48 good self-reported health,14,29,30,49 and having health
insurance.18,38 To improve FSS participation, it is imperative to clarify
which barriers and facilitators are of most relevance to particular low
uptake groups (eg, women, UK Asians). Previous reviews and synthe-
ses of qualitative studies have provided valuable insights into barriers
and facilitators to participation in other colorectal cancer screening
modalities.50,51 To date and to our knowledge, no review has provided
a synthesis of qualitative literature regarding the factors which impact
upon FSS intention and uptake. How the barriers and facilitators to
FSS uptake compare to other screening modalities is thus unknown.
While existing review literature25 is useful in providing confirmation
of associations regarding factors which affect FSS uptake and allows com-
parison to other colorectal cancer screening modalities through cross-sec-
tional evidence, it fails to provide depth of understanding regarding
barriers and facilitators identified. In addition, the saliency and relevance
of such barriers and facilitators amongst low uptake socio-demographic
groups is unknown. Therefore, the current review aimed to:
1 Synthesise qualitative evidence to obtain collective insight into and
greater depth of understanding of the key barriers and facilitators
of FSS intention and uptake.
2 Determine how relevant identified barriers and facilitators are
amongst low FSS uptake subgroups25: women, lower SES (inclusive
of high deprivation, low education, low income and unemployed)
and Asian minority ethnicity.
2 | METHODS
2.1 | Registration and guidelines
This review adhered to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) checklist52 and was registered
on the PROSPERO international prospective register of systematic
reviews (Registration number: CRD42019120446).53
2.2 | Eligibility criteria and article selection
In accordance with the participants, intervention, control, outcomes
and study design (PICOS) framework54 used to inform the search
strategy, eligibility criteria are outlined in Table 1.
ET searched four electronic databases: Ovid Embase (1947-), Ovid
Medline (1946-), Ovid PsycINFO (1806-) and ISI Web of Science (1900-),
all with end dates up to March 2019. A further search, with end dates up
to January 2020, was later completed to include any recent publications.
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ET/DOC/LA carefully chose search terms that incorporated all possible
phrases in relation to potential barriers and facilitators, socio demo-
graphic factors, colorectal cancer and FSS. Search terms used are pro-
vided in Table S1. Factors reported in reviews by Kerrison et al25 and
Smith et al55 informed this study's search terms, given they provided
generic search terms for barriers and facilitators suitable for reuse. ET
hand-searched the reference lists within the included articles and within
relevant reviews for any further studies which may meet the inclusion
criteria. ET used Google Scholar's ‘cited by’ functionality on included
studies, to check for any further studies to include. Searches were also
made based on the first and last author within the reference lists of
included articles. ET combined search results from each database into a
single Endnote file and removed duplicates. A three-stage approach to
study screening and selection was employed, whereby titles, then
abstracts, then full-texts were examined. Primary reviewer ET screened
and captured key exclusion reasons for all titles, and then screened the
remaining abstracts. Second reviewer MP screened 20% of titles, and
subsequently 100% of the remaining abstracts. ET and MP retrieved and
read the full text of all remaining studies to determine inclusion as per
the eligibility criteria. Any uncertainties for which eligibility was difficult
to determine or disagreements were discussed and resolved. To ensure
consensus on inclusion was reached, discussions took place between ET
and MP for title and abstract screening, and with the wider review team
(DOC, LA) for full-text screening. Cohen's Kappa56 was used to assess
inter-rater reliability scores, calculated for each screening stage, with
strong inter-rater reliability at title (k = .941), abstract (k = .865) and full-
text (k = .750) stages.
2.3 | Data extraction
Data extraction was separated into two stages. The first stage pro-
vided a synopsis of the study characteristics captured into a single
table, which summarised: research questions/study aims, the setting/
theoretical base, country, participant and data collection details,
method of analysis and outcome measure(s) for all included studies.
The second stage required extraction of data to perform the thematic
synthesis, where all text labelled as ‘results or findings’ were extracted
as verbatim into NVivo 12 Plus. This ensured both participant quotes
and author interpretations from each included study were extracted.
2.4 | Quality assessment
The nine-item Critical Appraisal Skills Program (CASP) tool for qualitative
research57 was used to assess the quality of the included studies. Guid-
ance notes for completion were followed, as outlined within the CASP
checklist, with responses of yes, cannot tell, and no selected. Second
reviewer SM assessed 30% of the included studies, with an inter-rater
reliability Cohen's Kappa score of complete reliability (k = 1.00). Studies
were not excluded from the review based on their quality ratings.
2.5 | Method of analysis
This review searched qualitative articles and followed the thematic
synthesis model: a three-stage procedure that involves line-by-line
coding, the development of descriptive subthemes and the generation
of analytical themes.58 The development of the descriptive subthemes
focussed on retaining a close representation of the data itself whilst
the creation of analytical themes went a step further and required
author interpretation and evaluation to be represented.
2.6 | Conducting the thematic synthesis
ET independently coded verbatim data to first group relevant content
and create descriptive themes. Following coding completion of the
first study, the reviewer then moved to code the next study in turn,
using existing descriptive themes where relevant and adding further
descriptive themes as necessary. By doing so for all studies, data was
collectively themed according to barriers and facilitators of FSS. Line-
by-line coding into descriptive subthemes was validated by the review
team, resulting in the development of 30 initial descriptive subthemes.
ET re-read the verbatim data within each descriptive theme to capture
similarities and contradictions. This helped form a line of argument
per descriptive subtheme based upon individual views and feelings.
Continuing the process of thematic synthesis,58 ET evaluated the ver-
batim data under each descriptive theme. Based upon commonality,
descriptive themes were synthesised into a tree-like structure with
eight overarching analytical themes (see Figure 2).
3 | RESULTS
3.1 | Study results
A total of 12 168 articles were identified from the database search up
until the end of January 2020. After the removal of duplicates and
screening, a total of 161 articles were selected for full-text review. A
TABLE 1 PICOS eligibility criteria
Participants • General population of any age, eligible to attend
FSS for colorectal cancer prevention
• Patients, not medical professionals
Intervention • Not relevant
Comparators/
control
• Not relevant
Outcomes • Qualitative data specifically reporting barriers
and facilitators of FSS intention and uptake
Study design • Qualitative and mixed-methods empirical study
designs
Other • Published in a peer-reviewed journal
• Written in English language
Abbreviations: FSS, flexible sigmoidoscopy screening; PICOS, participants,
intervention, control, outcomes, and study design.
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total of 10 studies were eligible for inclusion. Figure 1 provides a PRI-
SMA flowchart diagram showing exclusion and inclusion of studies at
every stage of the screening process.
3.2 | Study characteristics
Characteristics of included studies are summarized in Table S2. Included
studies shared commonality in research questions/aims proposed,
focusing on the barriers and facilitators of FSS. One study59 specifically
aimed to explore gender differences in colorectal cancer screening atti-
tudes, whilst eight studies captured gender sample characteristics.59-66
Two studies60,65 focused on how barriers and facilitators to screening
varied by ethnicity, reporting views from UK Asian ethnic minority indi-
viduals.60,65 No studies explicitly focused on the influence of lower SES
on FSS; however, sample characteristics of seven of the included stud-
ies59-62,64-66 captured views from participants with some degree of
lower SES. One article also captured the views of relatives of colorectal
cancer patients.66 Reference to theories as a framework, such as the
health belief model,67 were discussed within some studies to examine
behaviour.60,63,66 Studies were carried out in the UK,60-63,65,68 the
USA64,66,69 and Canada.59 Qualitative data collection methods included
focus groups,60,64,66 telephone semi-structured interviews59,63 and face-
to-face semi-structured interviews.61,62,65,68,69 The method of analysis
carried out by many of the included studies was thematic framework
analysis.59-63,66,69 Finally, nine studies59-66,68 reported outcomes regard-
ing screening intention, while eight studies61-66,68,69 reported outcomes
of screening behaviour.
3.3 | Study quality
Full results are provided in Figure S1. The studies generally met the
CASP tool criteria and were deemed of overall high methodological
quality. All studies provided clear research aims, appropriateness of
research design, clear statement of findings, and were of research
value. It was clear to identify in all but one study (90%) how data col-
lection had been conducted. The recruitment strategy was deemed
appropriate to the aims of the research in most studies (80%). Data
analysis was sufficiently rigorous, and the methodology chosen was
appropriate for most studies (80%). However, it was not clear in more
than half of studies (60%) whether ethical issues had been considered
ahead of data collection. Albeit likely that all studies did gain approval
in accordance with the ethical principles, this cannot be confirmed.
Given the adherence of most studies to high standards of qualitative
data analysis, it was surprising to discover only one study (10%) dis-
cussed the roles of the researcher and interviewee.63
3.4 | Thematic synthesis results
Key barriers and facilitators of FSS of high relevance to women and
UK Asian communities focussed upon the themes of ‘Procedural
anxieties’, ‘Religious and cultural-influenced health beliefs’ and ‘Com-
peting priorities’. Other themes highlighted key barriers of FSS inten-
tion and uptake in general; however, they were of less relevance to
women and UK Asian communities. An illustration of the structure of
descriptive subthemes and their relationships with the eight analytical
themes are illustrated in Figure 2. This tree diagram shows the rela-
tionships between the descriptive themes, displayed as oval and rect-
angular shapes, and analytical themes, displayed as hexagon shapes.
More specifically the oval shapes represent barriers and facilitators of
screening intention, and the rectangular shapes represent barriers and
facilitators of screening intention and behaviour. Quotes contained
within each theme have been stratified into barriers and facilitators of
screening intention, see Table S3a-c or barriers and facilitators of
screening behaviour, see Table S4a-c. The tables have also been fur-
ther stratified into general, women and UK Asian ethnicity groupings.
3.5 | Barriers and facilitators of screening intention
3.5.1 | Procedural anxieties
‘Anxiety regarding test invasiveness’ appeared to inhibit FSS inten-
tion.61,63,65,68 Some respondents reported to be horrified at the
thought, viewing FSS as an invasion of a private bodily area.70 Women
notably reported more embarrassment regarding the FSS test than
with breast or cervical screening.62,63 ‘Medical fear’ of doctors, hospi-
tals, and tests in general were also expressed, with the invitation letter
perceived negatively, igniting fear, panic and terror for some
individuals.63
3.5.2 | The power of social role and identity
No quotes were found from low uptake groups regarding this theme;
however, the authors provided the following comments. ‘Masculinity-
associated procrastination’ in relation to the procedure was raised as
an inhibitory factor amongst men in African-Caribbean communities,60
with the issue of ‘machismo’ viewed as an inhibitory factor. FSS was
considered a threat to masculinity, with further sexual overtones and
views that this was an unnatural procedure voiced, albeit indirect and
infrequent.63
‘Being responsible for your own health’ and making healthy life-
style choices reduced some individuals' perceived personal suscepti-
bility to colorectal cancer.62 Whilst others felt a real sense of
responsibility to use public funding and resources, viewing FSS as a
health maintenance procedure.59
3.5.3 | The fear of the unknown
‘Anxiety surrounding test results’ and ‘Avoidance due to underlying
fatalism’ inhibited individuals' intentions to accept FSS invita-
tions.61,63,66 To leave well alone and prevent psychological harm were
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shared beliefs of respondents who felt screening disturbed their cur-
rent state of good health and psychological equilibrium.63 More
explicitly, some Pakistani women believed that treatment alone cau-
sed cancer to advance.60 Individuals reported to be unable to cope
with a positive diagnosis or the word cancer, stating that they would
rather not know.60 In sum, the anticipation of fear and anxiety was
commonly echoed throughout the review literature.
‘Perceived susceptibility to colorectal cancer’ inhibited screening
intention in Gujarati Indian men, given a general lack of awareness of
prevalence and that their diet reduced prevalence of colorectal cancer
within their community.60,65
3.5.4 | Understanding the value of early detection
‘Knowledge and awareness of colorectal cancer’, the associated risks,
and the importance of early detection and prevention are factors
which can promote screening intention. Thus a lack of knowledge
about colorectal cancer by some Pakistani women was viewed as a
potential inhibitor of FSS.60 Furthermore, a lack of test information
was viewed by Gujarati Indian men to inflate their test anxiety levels
and inhibit screening intention.60 A lack of awareness by many of the
NHS England BSSP reported to bring about reactions of shock and
surprise on receiving the screening invitation.62 Men appeared to be
F IGURE 1 Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flowchart
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less aware than women of the colorectal cancer test modalities avail-
able to them; however, interestingly, a higher percentage of women
were aware but undecided as to whether to partake.59
‘The presence of symptoms’ as a cue to attend screening was
identified in several studies,60,63,64,68 including individuals of Pakistani
ethnicity.60 Furthermore, being asymptomatic was viewed by older
women as a valid reason to decline.63 Gujarati Indian women specifi-
cally spoke of the importance of symptoms being present to undergo
what they envisaged to be an invasive procedure.60
The ‘Likelihood of colorectal cancer based on family and own his-
tory’ of cancer affected FSS intention. For some, adverse family out-
comes ignited their own fatalistic beliefs and fears, whilst for others it
forged a need to be extra vigilant to detect cancer early given their
increased risk.62,63,66 Personal experience of any type of cancer also
heightened sensitivity due to a greater need for reassurance and early
detection.62 For some women, thinking about FSS brought back mem-
ories of having had a mastectomy.63
3.6 | Barriers and facilitators of screening intention
and behaviour
3.6.1 | Procedural anxieties
‘Shame and embarrassment’ were found to inhibit FSS intention59-
61,63-66 based upon general views. For some, however, it did not
inhibit FSS behaviour as it did not affect eventual decision making.63
Women reported a more personalised and intense expression of embar-
rassment in relation to medical professionals59 and a tendency to shy
away from the test.63 Levels of embarrassment were however less com-
mon among women who had experienced pregnancy and childbirth.59,63
A misunderstanding by some women regarding a patient's physical posi-
tion during the test was found to heighten anticipated levels of embar-
rassment, thus creating unnecessary concerns with the procedure
itself.64,66 Shame and embarrassment were notably found to inhibit both
screening intention and uptake amongst UK Asian groups.68 Indian and
Bangladeshi women revealed embarrassment as the sole reason for not
attending screening, even when they had initially accepted.65
‘Procedural pain and discomfort’ anticipated and experienced
from FSS was reported within several studies60,61,65,68,69 and for some
this contributed towards a preference for the FOBt.69 Some screeners
reported painful after-effects and difficulties with flatulence,61,68
while others reported the actual procedure to be uncomfortable yet
tolerable.69 Women's experience of painful mammograms also height-
ened nervousness to attend the FSS test.63 ‘Perforation anxiety’ due
to the risk of physical harm,63,64 specifically bowel perforation, also
resulted in some women's decision not to partake.
‘Test preparation difficulties’ were reported in multiple studies to
inhibit FSS intention and uptake.60-62,64,68 One woman reported this
to be the sole reason for not attending her upcoming appointment,62
with particular difficulties centred around drinking of the fluid laxative
diet and enema insertion.60-62,64,68 Women reported the experience
F IGURE 2 Tree diagram showing relationships between the descriptive themes (oval and rectangular shapes) and analytical themes (hexagon
shapes). Oval shapes represent barriers and facilitators of screening intention, rectangular shapes represent barriers and facilitators of screening
intention and behaviour.
[Correction added on 23 July 2020, after first online publication: Figure 2 caption is previously incorrect and has been corrected in this version.]
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as extremely unpleasant to administer, self-harm and the cause of
increased anxiety.60 Women spoke of a lack of test preparation infor-
mation, which affected their confidence and elevated their fears fur-
ther.68 Furthermore, one study found discomfort regarding test
preparations to impede individuals from repeat screening,68 this being
of relevance to countries such as the US where repeat FSS is rec-
ommended every 3 to 5 years.
‘The reassurance of the doctor narrative received during the test’
and the presence of a professional throughout the procedure posi-
tively enhanced patients' personal screening experience.61,64 The psy-
chological benefits of doctor narrative and presence are likely to
promote repeat screens and social encouragement among others to
screen,64 again of relevance to countries such as the United States
where repeat FSS is recommended every 3 to 5 years.
‘Avoidant decision making about the test’ was a strategy adopted
by non-responders to not to have to think about the invitation. By push-
ing it to the back of their minds, temporally at first, then indefinitely,
they protected themselves from consciously dealing with the worry and
fear of potential health threats that may result from FSS.63,65
3.6.2 | The influence of family, friends and medical
professionals
‘Family and peer pressure/support’ as factors associated with FSS inten-
tion and uptake are multifaceted and dependent upon the perspectives
of others within an individual's current social context. Peer pressure, a
lack of family support or encouragement were found to both promote
and inhibit screening intention and uptake.64,68 Others mentioned family
discussions about screening as commonplace, yet did not perceive
themselves as being influenced by their partners.63,64 The extent to
which screening participation was discussed differed by gender. Women
discussed screening tests often with friends and family, whose views
were largely in line with their own. Men, on the other hand, rarely dis-
cussed such matters with friends and family,63 and were thus potentially
less subject to verbal influence or pressure from peers or relatives.
Rather than recommendation from national bodies, patients
viewed a ‘Doctor/physician screening recommendation’, in which
personalised invitations from medical professionals promoted screen-
ing, to be of direct personal benefit.66,68,69 Furthermore, in one study,
Pakistani men were disinclined to attend unless advised to by their
GP.60 When questioned as to why respondents attended the test, 90%
said their physician had recommended the procedure.69 Overall, the lit-
erature supported the value of good doctor-patient relationships and
trust to up motivation levels and improve screening intention.64,68,69
‘Religious and cultural-influenced health beliefs’ impacted individ-
uals' perception of their susceptibility to colorectal cancer, particularly
amongst minority groups. A fibre-based diet was viewed to reduce
risks for colorectal cancer within Indian cultures.60 Moreover, a mis-
understanding that only men are at risk of colorectal cancer was
reported by Pakistani and African-Caribbean women.60 A lack of rec-
ognition of cancer was identified among African-Caribbean and Paki-
stani communities, where cancer was seen as a taboo and not their
cultural way. Finally, Pakistani men and women, in accordance with
their religious beliefs, disclosed the requirement for women to be
screened by a female endoscopist. In circumstances by which a female
endoscopist could not be guaranteed, Pakistani women responded
that they would not attend FSS.60
3.6.3 | The fear of the unknown
‘Fatalistic beliefs about colorectal cancer’ were demonstrated in
women non-screeners who had lost family or friends to colorectal
cancer.62 Some respondents concluded that their FSS invitation alone
signified an adverse outcome of colorectal cancer.68
3.6.4 | Peace of mind in knowing
Peace of mind was given as a reason from screeners as to why they
attended screening.62,69 Any experiences of discomfort and embar-
rassment were felt to be overridden by a personal need for reassur-
ance.69 Others referred to the importance of taking advantage of
potentially life-saving technology, accepting screening to avoid any
self-recriminations that could result from not doing so.64 Furthermore,
even intense anxiety about the procedure was reported by some
respondents to be negated by the need for reassurance.62
Among many respondents, including Pakistani women, ‘Reassur-
ance from early detection and prevention’ of colorectal cancer provided
comfort of knowing and catching cancer at its earlier stage.60 However,
some women non-screeners continued to compare the benefits of early
detection with the potential threat of an adverse outcome.62
The unexpected reality of the test and the ‘Ease of the procedure’
pleasantly surprised some patients, removing fears of partaking in
future FSS tests. Again, of particular relevance to countries such as
the United States, where repeat FSS is recommended every 3 to
5 years. Aside from the fear of visualization of polyps, the ‘Technical
sophistication of screening’ was also viewed as interesting, educa-
tional, and was provided as a reason for FSS modality preference.61
3.6.5 | (Un)necessary healthcare
Flexible sigmoidoscopy screening as an ‘Unnecessary healthcare’ proce-
dure was stated by a female non-screener who disclosed no intention to
treat future cancer should it occur.62 In England, FSS differs from other
forms of screening, in that it is not routine and is a once-only procedure.
For some individuals, opting to attend FSS was therefore implied to be a
deliberate choice requiring greater commitment.63
3.6.6 | Competing priorities
Childcare, carer, and work commitments were identified as factors
impeding some women's ability to free up time to attend certain
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screening slots.63,65,66,68 Particularly caring for ill or disabled children or
parents, or conflicting demands such as own ill health obstruct FSS
uptake.62 ‘Competing priorities’ were exacerbated by difficulties experi-
enced with rescheduling FSS appointments, inhibiting FSS uptake fur-
ther.65 The need to request unpaid leave was also viewed as a major
barrier for some.65,68 Yet, for a few women, such difficulties were still
secondary to an overall reluctance to attend.63 For individuals living cha-
otic lives, common in deprived circumstances, it was suggested that little
is left in reserve to deal with potentially negative outcomes of FSS, plac-
ing their focus firmly upon their family's immediate health concerns.62
4 | DISCUSSION
Key barriers to FSS intention and uptake centred upon ‘Procedural anxi-
eties’. Notably, ‘Shame and embarrassment’ 59-61,63-66,68 and, culturally,
the gender of medical professionals, were deemed pivotal to the test
itself. Feelings of unease were heightened in UK Asian women, who
expressed the requirement for a female nurse in order to attend.60 The
themes of embarrassment and feelings of vulnerability, particularly in
women, that emerged from this review correspond with findings of pro-
cedural anxieties from a previous qualitative review.50 McLachlan et al50
reported laxative bowel preparation to be the most burdensome part of
having a colonoscopy, the anticipation of pain, and feelings of embarrass-
ment and vulnerability were common amongst patients. ‘Anticipated pro-
cedural pain and discomfort’, and painful after-effects of the test
elevated anxiety levels61,64,66,68 consistent with previous quantitative
associations found between anticipated test pain and FSS uptake.25,42
Moreover, feeling relaxed and comfortable during the procedure was
found to be imperative to minimise risk of physical harm.50 ‘Perforation
anxiety’ was a concern raised by women,63,64 resulting in decisions for
some not to partake. Lower FSS intention and uptake in women due to
‘Procedural anxieties’, was particularly surprising given many women
have previously undergone invasive cervical cancer screening tests.
When making direct comparisons between FSS, and cervical and breast
cancer screening in terms of embarrassment and intrusiveness, women
viewed breast and cervical screening as more easily normalised as part of
being a woman.62 Furthermore, FSS requires invasive bowel preparation
procedures to be completed by individuals, which are found to cause
additional stress and anxiety.60-62,64,68
Social norms and conformity were demonstrated within UK Asian
communities and women with regards to FSS intention and uptake. A
lack of awareness of cancer was reported among Pakistani communi-
ties in which cancer was seen as a taboo and partaking in FSS was not
considered their cultural way. Furthermore, in accordance with reli-
gious beliefs, UK Asian men and women disclosed the need for
women to be screened by a female endoscopist. These findings corre-
spond with a previous qualitative review by Honein-AbouHaidar et
al51 who reported lack of awareness, fear of cancer and misconcep-
tions about colorectal cancer development within Indian, African-
Caribbean and Chinese American ethnic groups.
‘Competing priorities’ were reported to inhibit both FSS intention
and uptake. Due to wider family and work commitments, attending
screening was viewed by many women to be beyond their control. To
effectively increase FSS uptake, it is necessary to first address these
‘Competing priorities’ particularly faced by women. A qualitative review
by Honein-AbouHaidar et al51 reported competing life demands of work
and family to deter individuals from seeking colorectal cancer screening,
particularly within lower SES groups. Given this review did not discover
any qualitative studies that reported on factors that influence FSS inten-
tion and uptake within lower SES groups, further work is required to
understand whether ‘competing priorities’ is also a barrier faced by
lower SES groups, to FSS intention and uptake.
4.1 | Study limitations
The methodological approach demonstrated throughout the search
and screening procedure was both rigorous and robust. A systematic
and comprehensive search strategy was completed in compliance with
the PRISMA checklist.52 To eliminate reviewer bias and to ensure full
inclusion, a second reviewer duplicate screened all abstracts and full
texts during the screening process.54 Consistent with other recently
published reviews,55,70 we employed a three-stage screening proce-
dure in which only titles were screened in the first stage. Due to this,
and especially as a very high proportion of studies (79.5%) were
excluded on the basis of title, it is possible that eligible studies could
have been missed at this stage. However, we note that our review
included all seven59,60,62-64,66,69 of the qualitative studies identified in
the recent FSS review by Kerrison et al.25 Moreover, during the peer-
review process ET and MP each independently revisited 50% of the
excluded titles (n = 4839) and also read the accompanying abstract;
there was 100% agreement between the two reviewers that none of
the revisited papers were eligible for inclusion in the study. Thus, it is
very unlikely that this review failed to include eligible research.
A key review limitation was the inclusion of only published peer-
reviewed journals, excluding all grey literature, such as book chapters,
theses, and conferences abstracts. Such qualitative literature could
have potentially added to the review findings providing a richer
understanding of the barriers and facilitators of FSS most pertinent to
low uptake groups.71 Inclusion of grey literature can, however, be
challenging given it is time and resource intensive.72
All studies highlighted limitations of small sample sizes and or pur-
poseful quota sampling, stating that conclusions drawn from qualita-
tive data alone should remain tentative. Qualitative research
principles argue that findings are not intended to be generalisable, but
specific to a certain context, time and set of participants.58 This
review therefore echoes caution over generalisation of findings made
across different cultural and socio-political contexts.
4.2 | Future research and clinical implications
The gap between FSS intention and uptake requires further atten-
tion.29 This review presented data regarding both barriers and facilita-
tors of screening intention and screening behaviour (uptake). Greater
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evidence was provided in relation to screening intention, particularly
within UK Asian groups. Similar to previous literature, barriers were
found to account for a large proportion of screening intention.73 In
order to determine the barriers which explain FSS uptake, it is vital
that we direct qualitative research attention towards factors associ-
ated with screening behaviour (uptake) in addition to intention.74
To address ‘Procedural anxieties’, clinical action is being taken to
trial ways to improve and enhance comfort and modesty during FSS.
FSS is an un-sedated procedure; however, sedation can be requested.
Early BSSP data has found one in three patients to report moderate to
severe discomfort.75 Screening modifications are thus being trialled to
see if post-procedural pain is reduced when using water-assisted,
rather than the current CO2, insufflation for BSSP.
75
With regards to gender preference of medical professionals,
Stoffel et al76 investigated the preference for women to have a same-
gender practitioner. They revealed FSS intention to have a female
endoscopist to be significantly greater in disinclined women who were
first given the decoy male endoscopist. This compared to disinclined
women who were initially given by default a choice to make them-
selves regarding which gender of practitioner they prefer. This ‘nudge
technique’ thus warrants further trials to explore the ‘decoy effect’ as
an effective means of reducing perceived difficulty in screening deci-
sion and the influence on screening behaviour as well as intention.
Results confirmed the value individuals placed on personalised
doctor recommendation and how improved FSS intention, particularly
within UK Asian groups. Additional targeted primary care interven-
tions within areas with a high UK Asian population could potentially
further mobilise FSS interest through targeted GP recommendation
and awareness to UK Asian patients when approaching screening age.
Appraisal of existing UK-wide NHS interventions to increase FSS
uptake, which are largely paper based, require further validation
regarding their effectiveness on low uptake groups. Lengthy docu-
ments with complex and unfamiliar terminology can challenge groups
with low levels of health literacy and may lead to informational avoid-
ance.77 In order to better understand thought processes on receipt of
a written invitation, think-aloud studies on FSS may offer a potential
means to further understand the immediate barriers low uptake
groups face.78 Finally, considering efforts to optimize UK Asian ethnic
groups' participation in screening, community-based participatory
research has been recognised as an important approach to consider
when conducting intervention research aimed at improving screening
attitude, knowledge and behaviour.79
5 | CONCLUSIONS
This systematic review has examined and analysed qualitative evi-
dence concerning the barriers and facilitators of FSS intention and
uptake. Key barriers centred largely upon procedural anxieties.
Women, including UK Asian women, reported shame and embarrass-
ment, anticipated and experienced pain, perforation risk, and test
preparation difficulties to elevate their anxiety levels. Religious and
cultural-influenced health beliefs amongst UK Asian groups were also
reported to inhibit FSS intention and uptake. Competing priorities
such as caring commitments particularly impeded women's ability to
attend certain screening appointments. The review exposed a knowl-
edge gap concerning factors that most influence FSS intention and
uptake in lower SES groups, inclusive of those populations who are
highly deprived, of low income, low educated and unemployed. Foun-
dational qualitative work that builds an understanding of factors asso-
ciated with FSS intention and uptake amongst UK Asian and lower
SES groups is advised.
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